{"product_id":"coo-business-model-canvas","title":"The Cooper Companies, Inc. (COO): Business Model Canvas [June-2026 Updated]","description":"\u003cp\u003eThis ready-made Business Model Canvas gives you a practical, research-based view of how Company Name creates value through \u003cstrong\u003e130 countries\u003c\/strong\u003e of global operations, key partnerships with logistics, professional associations, eye care providers, fertility clinics, and distributors, and core businesses in contact lenses and fertility products. You will see the main customer groups, including optometrists, ophthalmologists, contact lens wearers, myopia management patients, fertility clinics, and hospitals, plus the key revenue drivers from contact lens sales, fertility business sales, premium lens products, regional sales, and service revenues, along with the main cost pressures from manufacturing, R\u0026amp;D, sales and marketing, logistics, and compliance.\u003c\/p\u003e\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Key Partnerships\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eKey partnerships\u003c\/strong\u003e are central to The Cooper Companies, Inc. because both CooperVision and CooperSurgical depend on outside clinical, logistics, and channel partners to reach customers at scale.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePartner group\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eRole in the business model\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003e\u003cstrong\u003eWhy it matters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCEVA Logistics\u003c\/td\u003e\n\u003ctd\u003eGlobal logistics and distribution support\u003c\/td\u003e\n \u003ctd\u003eHelps move contact lenses, surgical products, and related inventory through international supply chains\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmerican Optometric Association\u003c\/td\u003e\n\u003ctd\u003eProfessional association and industry relationship channel\u003c\/td\u003e\n \u003ctd\u003eSupports visibility, education, and professional trust in the eye care market\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEye care providers\u003c\/td\u003e\n\u003ctd\u003eClinical prescribing and patient-facing channel\u003c\/td\u003e\n \u003ctd\u003eDrive fitting, recommendation, adoption, and repeat use of contact lens products\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFertility clinics and hospitals\u003c\/td\u003e\n\u003ctd\u003eClinical adoption and procedure channel for fertility products\u003c\/td\u003e\n \u003ctd\u003eSupport product use in assisted reproductive care and other hospital-based settings\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal distributors\u003c\/td\u003e\n\u003ctd\u003eMarket access and regional reach\u003c\/td\u003e\n\u003ctd\u003eExtend product availability in countries where direct sales are less efficient\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eCEVA Logistics\u003c\/strong\u003e matters because The Cooper Companies, Inc. sells regulated medical products that need reliable storage, handling, and delivery. A logistics partner helps manage cross-border movement, customs coordination, warehousing, and time-sensitive replenishment. That is especially important for products that move through eye care practices, hospitals, and distributors, where delays can affect patient care and inventory availability.\u003c\/p\u003e\n\n\u003cp\u003eFor a Business Model Canvas, this partnership sits in the operations side of the model. It does not create the product, but it helps The Cooper Companies, Inc. deliver it consistently. In academic analysis, this is a good example of how a medtech company lowers operational risk without owning every part of the supply chain.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eSupports international product flow\u003c\/li\u003e\n\u003cli\u003eReduces delivery and inventory risk\u003c\/li\u003e\n\u003cli\u003eHelps maintain service levels across regions\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eAmerican Optometric Association\u003c\/strong\u003e is important because professional associations shape clinical awareness, education, and prescribing behavior in eye care. For a contact lens company, relationships with optometric organizations matter because optometrists often influence brand selection, fitting decisions, and patient retention. The partnership value is indirect but powerful: it helps build trust in the category and keeps the company close to the professional community that recommends vision care products.\u003c\/p\u003e\n\n\u003cp\u003eThis partnership affects strategy in two ways. First, it supports brand credibility with professionals. Second, it helps the company stay connected to practice trends, clinical preferences, and education needs. In a case study, you can treat this as a demand-shaping partnership rather than a pure sales channel.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eBuilds professional credibility\u003c\/li\u003e\n\u003cli\u003eSupports education and awareness\u003c\/li\u003e\n\u003cli\u003eInfluences clinical adoption\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eEye care providers\u003c\/strong\u003e are a core partner group in the CooperVision business model. These include optometrists, ophthalmologists, clinics, and retail eye care practices that fit and recommend contact lenses. They are essential because contact lens demand depends on professional fitting, prescription renewal, and patient follow-up. Without these providers, the company's access to end users would be much weaker.\u003c\/p\u003e\n\n\u003cp\u003eThe partnership is commercially important because eye care providers sit at the point of sale and the point of clinical trust. Their recommendation affects product mix, replacement behavior, and patient loyalty. For academic writing, this is a clear example of a B2B2C model, where the company sells to professionals who influence the final consumer.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eDrive prescribing and fitting decisions\u003c\/li\u003e\n\u003cli\u003eInfluence patient adoption and retention\u003c\/li\u003e\n \u003cli\u003eSupport recurring demand through renewals and refits\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFertility clinics and hospitals\u003c\/strong\u003e are central to CooperSurgical's business model. These institutions are the primary setting for many fertility-related products and services, including assisted reproductive care workflows. The relationship is not just transactional. It depends on clinical integration, physician preference, procurement systems, and long-term purchasing relationships.\u003c\/p\u003e\n\n\u003cp\u003eHospitals and fertility clinics matter because they concentrate procedure volume, clinical expertise, and purchasing decisions. That gives The Cooper Companies, Inc. a way to sell into specialized care environments where product reliability and clinical support are more important than mass-market advertising. In a Business Model Canvas, this is a direct institutional channel that supports product adoption and recurring use.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eSupport specialized clinical workflows\u003c\/li\u003e\n\u003cli\u003eConcentrate purchasing decisions in institutional buyers\u003c\/li\u003e\n \u003cli\u003eHelp sustain recurring product demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eGlobal distributors\u003c\/strong\u003e expand market access for both business segments, especially where direct sales coverage is limited or inefficient. Distributors matter in international medical device markets because they already have local regulatory knowledge, customer relationships, and sales infrastructure. That lowers the cost and complexity of entering or scaling in a country.\u003c\/p\u003e\n\n\u003cp\u003eThis partnership is especially important for a company with a global footprint. Distributors can speed access to smaller markets, improve service coverage, and support local language and regulatory needs. For academic work, this is a textbook example of a channel partnership that trades margin for reach.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePartnership type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eMain value\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBusiness model effect\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics partner\u003c\/td\u003e\n\u003ctd\u003eDelivery and supply chain execution\u003c\/td\u003e\n\u003ctd\u003eImproves operational reliability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProfessional association\u003c\/td\u003e\n\u003ctd\u003eTrust and education\u003c\/td\u003e\n\u003ctd\u003eSupports clinical awareness\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEye care providers\u003c\/td\u003e\n\u003ctd\u003ePrescription and fitting channel\u003c\/td\u003e\n\u003ctd\u003eDrives recurring demand\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFertility clinics and hospitals\u003c\/td\u003e\n\u003ctd\u003eInstitutional purchasing and clinical adoption\u003c\/td\u003e\n \u003ctd\u003eSupports specialized product sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal distributors\u003c\/td\u003e\n\u003ctd\u003eLocal market access\u003c\/td\u003e\n\u003ctd\u003eExtends geographic reach\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe partnership structure shows that The Cooper Companies, Inc. does not rely on one sales path. It uses logistics, professional influence, clinical channels, and distribution networks together, which reduces dependence on any single customer type and helps the company reach both consumers and institutions.\u003c\/p\u003e\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Key Activities\u003c\/h2\u003e\n\n\u003cp\u003eThe Cooper Companies, Inc. runs its business through \u003cstrong\u003e2\u003c\/strong\u003e reportable segments: CooperVision and CooperSurgical. Its key activities are centered on product innovation, regulated manufacturing, global supply execution, and portfolio management across vision care and fertility care.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eKey activity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBusiness purpose\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eWhy it matters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContact lens R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003eNew lens materials, designs, and wear options\u003c\/td\u003e\n \u003ctd\u003eSupports product differentiation and repeat purchases\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFertility product development\u003c\/td\u003e\n\u003ctd\u003eTools, consumables, and systems used in reproductive medicine\u003c\/td\u003e\n \u003ctd\u003eExpands the medical technology portfolio beyond vision care\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSilicone hydrogel manufacturing\u003c\/td\u003e\n\u003ctd\u003eProduction of high oxygen-permeable soft contact lenses\u003c\/td\u003e\n \u003ctd\u003eDirectly affects product quality, supply, and gross margin\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal distribution and logistics\u003c\/td\u003e\n\u003ctd\u003eMoving products to clinics, retailers, and distributors worldwide\u003c\/td\u003e\n \u003ctd\u003eDetermines service levels, inventory availability, and delivery speed\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStrategic portfolio review\u003c\/td\u003e\n\u003ctd\u003eAssessing product lines, markets, and capital allocation\u003c\/td\u003e\n \u003ctd\u003eHelps shift resources toward higher-return areas\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eContact lens R\u0026amp;D\u003c\/strong\u003e is the core value-creation engine in CooperVision. The company must keep improving lens comfort, oxygen performance, moisture retention, prescription range, and wear schedules. In this business, small changes in material science can drive large commercial effects because lenses are often replaced regularly and performance differences influence brand switching, doctor recommendations, and patient retention. R\u0026amp;D also matters because the contact lens market is tightly linked to clinical trust and regulatory approval.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eLens material science\u003c\/li\u003e\n\u003cli\u003eOptical design and prescription coverage\u003c\/li\u003e\n \u003cli\u003eComfort and wear-time performance\u003c\/li\u003e\n\u003cli\u003eClinical testing and regulatory support\u003c\/li\u003e\n\u003cli\u003eIteration on daily, monthly, and specialty lens formats\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFertility product development\u003c\/strong\u003e sits inside CooperSurgical and covers tools used in in vitro fertilization and related reproductive procedures. This activity includes development work for laboratory and clinical products that support embryo handling, storage, and treatment workflows. The business value is not just selling devices; it is selling mission-critical products used in a highly specialized medical setting where accuracy, consistency, and regulatory compliance matter. Product development in this area helps broaden the company beyond contact lenses and creates exposure to a separate healthcare demand stream.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eActivity area\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eOperational focus\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eFinancial link\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContact lens R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003eMaterials, design, wear performance\u003c\/td\u003e\n\u003ctd\u003eSupports recurring revenue through repeat purchases\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFertility product development\u003c\/td\u003e\n\u003ctd\u003eClinical tools and workflow products\u003c\/td\u003e\n\u003ctd\u003eSupports higher-value medical technology sales\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing\u003c\/td\u003e\n\u003ctd\u003eQuality control, yield, throughput\u003c\/td\u003e\n\u003ctd\u003eAffects gross margin and inventory efficiency\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution\u003c\/td\u003e\n\u003ctd\u003eWarehousing, shipping, service levels\u003c\/td\u003e\n\u003ctd\u003eAffects working capital and customer retention\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eSilicone hydrogel manufacturing\u003c\/strong\u003e is one of the most important operating activities because silicone hydrogel is the material platform behind many premium soft contact lenses. This manufacturing process requires control over chemistry, precision molding, sterilization, and quality systems. It is capital-intensive and operationally sensitive, which means production stability matters for both cost structure and supply reliability. If output slips, the company can face missed shipments, higher scrap, and slower inventory turns. If it improves yield, the company can protect margin and improve service.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eMaterial formulation\u003c\/li\u003e\n\u003cli\u003ePrecision molding and finishing\u003c\/li\u003e\n\u003cli\u003eSterilization and packaging\u003c\/li\u003e\n\u003cli\u003eQuality assurance and batch release\u003c\/li\u003e\n\u003cli\u003eYield and waste reduction\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eGlobal distribution and logistics\u003c\/strong\u003e connect the company's factories to eye-care professionals, clinics, hospitals, distributors, and retailers across multiple countries. This activity is important because the products are time-sensitive, regulated, and often managed through replenishment cycles. Logistics performance affects customer satisfaction, inventory availability, and cash tied up in stock. In a business with recurring demand, reliable delivery can be as important as product features because poor service can push customers to substitute products from competitors.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLogistics function\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBusiness impact\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWarehousing\u003c\/td\u003e\n\u003ctd\u003eSupports inventory availability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrder fulfillment\u003c\/td\u003e\n\u003ctd\u003eSupports on-time delivery\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCross-border shipping\u003c\/td\u003e\n\u003ctd\u003eSupports international sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory planning\u003c\/td\u003e\n\u003ctd\u003eReduces stockouts and excess inventory\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eStrategic portfolio review\u003c\/strong\u003e is the management activity that decides where capital, R\u0026amp;D, and operating attention should go. For a company with \u003cstrong\u003e2\u003c\/strong\u003e segments and different demand drivers, portfolio review is not a side task; it is part of how management protects return on invested capital. This includes evaluating which products deserve more R\u0026amp;D, which geographies need more manufacturing support, and which businesses fit the long-term plan. It also helps the company balance higher-margin recurring products against slower-moving or lower-return lines.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eReview product profitability\u003c\/li\u003e\n\u003cli\u003ePrioritize higher-return innovation\u003c\/li\u003e\n\u003cli\u003eShift resources between segments\u003c\/li\u003e\n\u003cli\u003eEvaluate geographic demand patterns\u003c\/li\u003e\n\u003cli\u003eAlign manufacturing with demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe key activities work together as one operating system: R\u0026amp;D creates products, manufacturing scales them, logistics delivers them, and portfolio review decides where to focus future spending. In business model canvas terms, this is how the company turns technical know-how and regulated production into recurring sales in vision care and fertility care.\u003c\/p\u003e\n\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Key Resources\u003c\/h2\u003e\n\n\u003cp\u003eThe Cooper Companies, Inc. depends on two operating engines, \u003cstrong\u003eCooperVision\u003c\/strong\u003e and \u003cstrong\u003eCooperSurgical\u003c\/strong\u003e, plus two high-value product brands, \u003cstrong\u003eMyDay\u003c\/strong\u003e and \u003cstrong\u003eMiSight 1 day\u003c\/strong\u003e. Its resource base is strengthened by sales and operations in \u003cstrong\u003e130 countries\u003c\/strong\u003e and by cash generation from a business model built around recurring, consumable products.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eKey resource\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBusiness area\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBusiness model role\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eReal-life data\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperVision\u003c\/td\u003e\n\u003ctd\u003eContact lenses\u003c\/td\u003e\n\u003ctd\u003ePrimary product and brand platform\u003c\/td\u003e\n\u003ctd\u003eOne of the company's two operating businesses\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperSurgical\u003c\/td\u003e\n\u003ctd\u003eWomen's health and fertility\u003c\/td\u003e\n\u003ctd\u003eSecond operating business and diversification source\u003c\/td\u003e\n \u003ctd\u003eOne of the company's two operating businesses\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMyDay\u003c\/td\u003e\n\u003ctd\u003eContact lenses\u003c\/td\u003e\n\u003ctd\u003ePremium daily disposable brand\u003c\/td\u003e\n\u003ctd\u003eMyDay brand\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMiSight 1 day\u003c\/td\u003e\n\u003ctd\u003eMyopia management\u003c\/td\u003e\n\u003ctd\u003eClinical and differentiated growth brand\u003c\/td\u003e\n \u003ctd\u003eMiSight 1 day brand\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal distribution\u003c\/td\u003e\n\u003ctd\u003eCommercial footprint\u003c\/td\u003e\n\u003ctd\u003eMarket access and revenue reach\u003c\/td\u003e\n\u003ctd\u003e130 countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eCooperVision\u003c\/strong\u003e is the company's largest operating resource because it gives The Cooper Companies, Inc. a broad base in contact lenses. That matters because contact lenses are recurring-use products, so the business depends less on one-time sales and more on repeat buying behavior. For a business model canvas, this resource supports value creation through product design, optical expertise, and channel relationships with eye care professionals and distributors.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCooperSurgical\u003c\/strong\u003e is the second major resource because it broadens the company beyond contact lenses. It gives the company exposure to fertility and women's health markets, which can reduce dependence on one product category. In business model terms, this matters because it spreads commercial risk and gives the company more ways to use its sales network, clinical relationships, and product development capabilities.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMyDay\u003c\/strong\u003e and \u003cstrong\u003eMiSight 1 day\u003c\/strong\u003e are important brand assets inside CooperVision. MyDay supports the premium daily disposable lens position. MiSight 1 day is a differentiated myopia management brand, and the name itself signals the product format. These brands matter because strong brands can support pricing power, customer loyalty, and clinician preference, which are all key resources in a consumables business.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMyDay\u003c\/strong\u003e supports premium positioning in daily disposable lenses.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMiSight 1 day\u003c\/strong\u003e supports the myopia management category.\u003c\/li\u003e\n \u003cli\u003eBoth brands strengthen repeat purchase behavior.\u003c\/li\u003e\n \u003cli\u003eBoth brands help the company compete through product differentiation, not only price.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe company's reach across \u003cstrong\u003e130 countries\u003c\/strong\u003e is a major resource because it expands access to customers, eye care professionals, and distribution partners. This global footprint matters in the canvas because it supports scale, local market penetration, and resilience across regions. A company with sales in 130 countries can spread demand across many markets instead of relying on a single geography.\u003c\/p\u003e\n\n\u003cp\u003eThe global footprint also supports resource sharing across manufacturing, logistics, regulatory work, and commercial execution. In practical terms, that means the company can serve multiple markets from a coordinated operating base. For an academic analysis, this is a strong example of how geography itself can be a strategic resource when it is tied to product supply and customer access.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStrong free cash flow\u003c\/strong\u003e is a financial resource because cash from operations gives the company flexibility to fund research, product launches, acquisitions, working capital, and debt service. Free cash flow is the cash left after capital spending, so it shows how much money a business can keep and redeploy. In the business model canvas, this resource matters because it supports growth without depending entirely on outside financing.\u003c\/p\u003e\n\n\u003cp\u003eFree cash flow is especially important for a company with medical device and specialty health products because these businesses need ongoing spending on product development, quality systems, regulatory work, and global distribution. That makes cash generation a strategic resource, not just a finance metric.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eCooperVision\u003c\/strong\u003e: recurring contact lens demand supports repeat sales.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eCooperSurgical\u003c\/strong\u003e: adds diversification across fertility and women's health.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMyDay\u003c\/strong\u003e: premium daily disposable brand asset.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMiSight 1 day\u003c\/strong\u003e: differentiated myopia management brand asset.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003e130 countries\u003c\/strong\u003e: global commercial reach.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFree cash flow\u003c\/strong\u003e: internal funding source for growth and investment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResource type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eWhy it matters\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCanvas link\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrand asset\u003c\/td\u003e\n\u003ctd\u003eSupports pricing and loyalty\u003c\/td\u003e\n\u003ctd\u003eValue proposition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBusiness segment\u003c\/td\u003e\n\u003ctd\u003eCreates scale and diversification\u003c\/td\u003e\n\u003ctd\u003eKey resources\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal footprint\u003c\/td\u003e\n\u003ctd\u003eExpands market access\u003c\/td\u003e\n\u003ctd\u003eChannels\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree cash flow\u003c\/td\u003e\n\u003ctd\u003eFunds reinvestment and flexibility\u003c\/td\u003e\n\u003ctd\u003eCost structure and financing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Value Propositions\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003ePremium daily disposable lenses\u003c\/strong\u003e are the core consumer value proposition in CooperVision. The company sells soft contact lenses designed for daily replacement, which means \u003cstrong\u003e1 pair per day\u003c\/strong\u003e instead of cleaning, storing, and reusing lenses. That matters because daily disposables reduce handling, cut the need for lens care solutions, and fit patients who want convenience and hygiene in one product.\u003c\/p\u003e\n\n\u003cp\u003eCooperCompanies' lens portfolio also includes toric lenses for astigmatism and multifocal lenses for presbyopia, so the daily disposable offer is not just about convenience. It is about widening the number of patients who can stay in contact lenses as their vision needs change. That creates a higher-value offer than standard spherical lenses alone.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue proposition area\u003c\/td\u003e\n\u003ctd\u003eReal-life number or amount\u003c\/td\u003e\n\u003ctd\u003eBusiness relevance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDaily replacement cycle\u003c\/td\u003e\n\u003ctd\u003e1 day\u003c\/td\u003e\n\u003ctd\u003eRemoves cleaning and storage steps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWearer usage over a year\u003c\/td\u003e\n\u003ctd\u003e365 days\u003c\/td\u003e\n\u003ctd\u003eShows recurring consumption and repeat sales potential\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical focus\u003c\/td\u003e\n\u003ctd\u003eDaily disposable format\u003c\/td\u003e\n\u003ctd\u003eSupports hygiene-driven positioning\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDaily disposable lenses create convenience for patients who do not want lens care routines.\u003c\/li\u003e\n \u003cli\u003eThey support eye care practitioners who want simple fitting and replacement patterns.\u003c\/li\u003e\n \u003cli\u003eThey can improve retention because patients often prefer easier-to-use lenses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eMyopia management solutions\u003c\/strong\u003e are a major growth value proposition. CooperVision's MiSight 1 day is positioned for children with myopia, which is near-sightedness. In its 3-year clinical trial, MiSight 1 day was associated with a \u003cstrong\u003e59%\u003c\/strong\u003e reduction in myopia progression and a \u003cstrong\u003e52%\u003c\/strong\u003e reduction in axial elongation compared with control. Axial elongation is the lengthening of the eye, and it matters because faster elongation is linked to higher long-term vision risk.\u003c\/p\u003e\n\n\u003cp\u003eThis is a stronger value proposition than a standard corrective lens because it addresses both vision correction and disease management. That helps CooperCompanies move from a one-time product sale to a specialist, medically relevant category where parents and eye care professionals may accept premium pricing.\u003c\/p\u003e\n\n\u003cp\u003eThe business case is clear in academic terms: if a product can slow progression by \u003cstrong\u003e59%\u003c\/strong\u003e, the company is not just selling a lens. It is selling an outcome linked to future eye health concerns.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMyopia management expands the addressable market beyond ordinary vision correction.\u003c\/li\u003e\n \u003cli\u003eIt supports premium pricing because the product has a clinical performance claim.\u003c\/li\u003e\n \u003cli\u003eIt strengthens the company's relationship with eye care providers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003ePresbyopia correction lenses\u003c\/strong\u003e address age-related near-vision loss. Presbyopia usually becomes noticeable in the 40s, and contact lens solutions for this segment matter because many wearers want to keep using lenses instead of switching to readers or glasses only. CooperCompanies' multifocal and presbyopia-focused lenses let the company serve adults who need both distance and near vision correction in one product category.\u003c\/p\u003e\n\n\u003cp\u003eFrom a business model perspective, presbyopia products widen the life cycle of the customer. A wearer may start with standard lenses, move into toric lenses if astigmatism is present, and later shift into multifocal lenses as presbyopia appears. That raises the value of the customer relationship because the company can serve more than one vision stage over time.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePresbyopia solutions protect customer retention as needs change with age.\u003c\/li\u003e\n \u003cli\u003eThey reduce the chance that wearers abandon contact lenses for glasses alone.\u003c\/li\u003e\n \u003cli\u003eThey support a more complete product ladder in the vision care portfolio.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFertility and women's health products\u003c\/strong\u003e are the main value proposition of CooperSurgical. The portfolio serves fertility clinics, hospitals, and women's health providers with products used in assisted reproduction, gynecology, and related procedures. This is a high-need category because customers often rely on specialized consumables and devices in clinically sensitive workflows.\u003c\/p\u003e\n\n\u003cp\u003eThe appeal is not consumer convenience in the same way as contact lenses. It is clinical reliability, procedural support, and workflow fit. In fertility, products are used in highly specialized treatment pathways where precision and consistency matter. In women's health, the company serves recurring medical needs across office-based and hospital settings.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eBusiness segment\u003c\/td\u003e\n\u003ctd\u003eValue proposition type\u003c\/td\u003e\n\u003ctd\u003eCustomer group\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperVision\u003c\/td\u003e\n\u003ctd\u003eVision correction and eye health\u003c\/td\u003e\n\u003ctd\u003eEye care professionals and patients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperSurgical\u003c\/td\u003e\n\u003ctd\u003eFertility and women's health support\u003c\/td\u003e\n\u003ctd\u003eClinics, hospitals, and physicians\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eSustainability-focused product design\u003c\/strong\u003e is increasingly part of the company's value proposition because product format affects waste, packaging, and usage behavior. Daily disposable lenses are central here. A daily replacement model means no cleaning case and no nightly storage routine, which changes how the product is used and discarded.\u003c\/p\u003e\n\n\u003cp\u003eThe sustainability angle is practical, not promotional. If a wearer uses \u003cstrong\u003e1\u003c\/strong\u003e pair per day, that equals \u003cstrong\u003e365\u003c\/strong\u003e pairs per year. That structure increases unit consumption but can reduce the use of care solutions and storage accessories. For academic analysis, this creates a trade-off: less care-product dependency, but more single-use lens waste.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDaily disposables reduce the need for lens care solution.\u003c\/li\u003e\n \u003cli\u003eThey eliminate repeated cleaning and storage steps.\u003c\/li\u003e\n \u003cli\u003eThey support a simpler user routine, which can improve adherence.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe sustainability value proposition also matters for corporate customers and healthcare buyers that evaluate product design alongside clinical performance. In this business, sustainability is tied to product format, packaging, and waste footprint, not just to corporate messaging.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eDesign feature\u003c\/td\u003e\n\u003ctd\u003eOperational effect\u003c\/td\u003e\n\u003ctd\u003eStrategic impact\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDaily disposable format\u003c\/td\u003e\n\u003ctd\u003e365 replacement cycles per year\u003c\/td\u003e\n\u003ctd\u003eHigher repeat demand\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNo lens case use\u003c\/td\u003e\n\u003ctd\u003eLess accessory dependence\u003c\/td\u003e\n\u003ctd\u003eSimpler patient routine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNo cleaning step\u003c\/td\u003e\n\u003ctd\u003eNo nightly maintenance\u003c\/td\u003e\n\u003ctd\u003eLower friction for adoption\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Customer Relationships\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eClinician-led support\u003c\/strong\u003e is the core relationship model in Cooper Companies, Inc.'s eye care business. The company sells through eye care professionals, so the relationship starts with clinicians rather than with end consumers. That matters because prescribing, fitting, and follow-up drive repeat use in contact lenses and surgical eye care.\u003c\/p\u003e\n\u003cp\u003eThe company's customer relationship model depends on professional trust, repeat ordering, and fit-based product selection. In contact lenses, the relationship is not a one-time sale; it is built around ongoing clinical fit, patient compliance, and reorder behavior.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eCustomer relationship element\u003c\/th\u003e\n\u003cth\u003eBusiness impact\u003c\/th\u003e\n\u003cth\u003eWhat it means in practice\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinician-led support\u003c\/td\u003e\n\u003ctd\u003eHigher prescribing trust\u003c\/td\u003e\n\u003ctd\u003eEye care professionals influence product selection and refits\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProfessional education programs\u003c\/td\u003e\n\u003ctd\u003eBetter product adoption\u003c\/td\u003e\n\u003ctd\u003eTraining supports fitting, patient selection, and clinical confidence\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegional service center support\u003c\/td\u003e\n\u003ctd\u003eFaster issue resolution\u003c\/td\u003e\n\u003ctd\u003eLocal support helps with ordering, logistics, and account service\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLong-term account relationships\u003c\/td\u003e\n\u003ctd\u003eRecurring revenue\u003c\/td\u003e\n\u003ctd\u003ePractices and distributors reorder products over time\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMyopia community engagement\u003c\/td\u003e\n\u003ctd\u003eClinical awareness and demand creation\u003c\/td\u003e\n\u003ctd\u003eEducation around myopia management supports adoption of treatment approaches\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eProfessional education programs\u003c\/strong\u003e are important because contact lens success depends on correct fitting and patient management. For a company selling through eye care professionals, education is part of the customer relationship, not just marketing. Training programs help clinicians understand lens selection, fitting protocols, and patient follow-up, which supports adoption and repeat business.\u003c\/p\u003e\n\u003cp\u003eThis relationship style is especially relevant in myopia management, where clinicians need updated guidance on diagnosis, progression monitoring, and treatment choices. Education reduces friction in prescribing and can improve practice confidence.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eClinical training supports product fit and re-fit decisions.\u003c\/li\u003e\n \u003cli\u003eEducation lowers the barrier to adopting new lens technologies.\u003c\/li\u003e\n \u003cli\u003ePractice-level knowledge improves reorder consistency.\u003c\/li\u003e\n \u003cli\u003eMyopia education helps clinicians discuss treatment options with parents and patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eRegional service center support\u003c\/strong\u003e links the company to customers after the sale. In a business that depends on recurring orders and clinical continuity, service quality matters as much as product quality. Regional support centers help with order handling, account questions, and issue resolution close to the customer.\u003c\/p\u003e\n\u003cp\u003eThis matters because a delayed order or service failure can disrupt a practice's supply chain and patient flow. For a medical products company, service reliability is part of the value proposition.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eLong-term account relationships\u003c\/strong\u003e are central to the business model because practices, distributors, and clinics often reorder over long periods. That creates retention value. In simple terms, customer relationships are not built on one transaction; they are built on repeated clinical use and replenishment.\u003c\/p\u003e\n\u003cp\u003eThis relationship structure supports revenue stability. It also makes switching costs higher, because clinicians may not want to retrain staff or change fitting routines unless the alternative is clearly better.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eRepeat ordering supports revenue visibility.\u003c\/li\u003e\n \u003cli\u003eEstablished accounts reduce selling costs over time.\u003c\/li\u003e\n \u003cli\u003eLong-term relationships improve product continuity in clinics.\u003c\/li\u003e\n \u003cli\u003eAccount retention is especially important in subscription-like replenishment cycles.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eMyopia community engagement\u003c\/strong\u003e is part education and part professional network building. Myopia management has become a major clinical focus because it requires sustained discussion among optometrists, ophthalmologists, parents, and patients. For a company in this market, engagement with the professional community helps create awareness and keep the condition high on the clinical agenda.\u003c\/p\u003e\n\u003cp\u003eThat relationship works because myopia control is not a one-visit decision. It usually involves patient monitoring, parent communication, and ongoing clinician involvement.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eRelationship channel\u003c\/th\u003e\n\u003cth\u003eWho it serves\u003c\/th\u003e\n\u003cth\u003eWhy it matters\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinician-led support\u003c\/td\u003e\n\u003ctd\u003eEye care professionals\u003c\/td\u003e\n\u003ctd\u003eDrives prescribing and patient fit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProfessional education programs\u003c\/td\u003e\n\u003ctd\u003eClinicians and practice staff\u003c\/td\u003e\n\u003ctd\u003eImproves adoption and consistent use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegional service center support\u003c\/td\u003e\n\u003ctd\u003ePractices and account teams\u003c\/td\u003e\n\u003ctd\u003eSupports ordering and service continuity\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLong-term account relationships\u003c\/td\u003e\n\u003ctd\u003eClinics, distributors, and practices\u003c\/td\u003e\n\u003ctd\u003eDrives repeat revenue and retention\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMyopia community engagement\u003c\/td\u003e\n\u003ctd\u003eClinicians and families\u003c\/td\u003e\n\u003ctd\u003eBuilds awareness of treatment pathways\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe customer relationship model is relationship-heavy, not transaction-heavy. That means the company depends on trust, training, and recurring clinical use more than on one-off purchases.\u003c\/p\u003e\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Channels\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eEye care professional network\u003c\/strong\u003e is the core channel. The company reaches end customers through eye care professionals who fit and prescribe contact lenses and recommend related eye care products. This channel matters because the purchase decision is usually made through clinical advice, not direct consumer browsing.\u003c\/p\u003e\n\u003cp\u003eThe channel structure is built around professional prescription and fitting workflows:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEye care professionals identify patient needs and match lens type, replacement cycle, and wear schedule.\u003c\/li\u003e\n \u003cli\u003ePatients receive product recommendations during exams and follow-up visits.\u003c\/li\u003e\n \u003cli\u003eRepeat purchases are supported by ongoing care relationships rather than one-time transactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRegional service centers\u003c\/strong\u003e support order handling, customer service, and local delivery coordination. These centers matter because contact lens supply depends on speed, availability, and accurate fulfillment across different markets.\u003c\/p\u003e\n\u003cp\u003eFor a business model canvas, this channel sits between production and end use. It reduces friction in replenishment, supports localized service standards, and helps the company manage demand across countries with different regulatory and distribution requirements.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eChannel\u003c\/td\u003e\n\u003ctd\u003eFunction\u003c\/td\u003e\n\u003ctd\u003eBusiness impact\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEye care professional network\u003c\/td\u003e\n\u003ctd\u003eProduct fitting, prescription, recommendation\u003c\/td\u003e\n \u003ctd\u003eDrives demand at the point of clinical decision\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegional service centers\u003c\/td\u003e\n\u003ctd\u003eOrder support, fulfillment coordination, customer service\u003c\/td\u003e\n \u003ctd\u003eImproves availability and delivery reliability\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales teams\u003c\/td\u003e\n\u003ctd\u003eAccount management, product education, relationship building\u003c\/td\u003e\n \u003ctd\u003eSupports adoption and retention with professional buyers\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal distributor network\u003c\/td\u003e\n\u003ctd\u003eMarket access and local market coverage\u003c\/td\u003e\n\u003ctd\u003eExpands reach in markets where direct coverage is less efficient\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical and symposium events\u003c\/td\u003e\n\u003ctd\u003eScientific education and professional engagement\u003c\/td\u003e\n \u003ctd\u003eSupports trust, product knowledge, and brand preference\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eDirect sales teams\u003c\/strong\u003e are a high-touch channel for professional accounts, especially where the company needs account-level support, training, and commercial follow-up. This channel matters because it helps convert product features into practical value for eye care professionals.\u003c\/p\u003e\n\u003cp\u003eDirect sales activity usually supports:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePractice-level product education\u003c\/li\u003e\n\u003cli\u003eNew product launch adoption\u003c\/li\u003e\n\u003cli\u003eReorder continuity\u003c\/li\u003e\n\u003cli\u003eAccount retention\u003c\/li\u003e\n\u003cli\u003eFeedback from prescribers and dispensers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eGlobal distributor network\u003c\/strong\u003e extends market reach where local intermediaries are the most efficient way to sell and service customers. This channel matters in international markets because it lowers the need for the company to build a full direct commercial structure in every geography.\u003c\/p\u003e\n\u003cp\u003eDistributor channels are especially important when the business needs:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLocal market knowledge\u003c\/li\u003e\n\u003cli\u003eRegulatory and import handling\u003c\/li\u003e\n\u003cli\u003eLanguage and service coverage\u003c\/li\u003e\n\u003cli\u003eSmaller-market access\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eClinical and symposium events\u003c\/strong\u003e are a knowledge-based channel. They help the company communicate clinical evidence, product performance, and fitting practices to eye care professionals. This matters because contact lens adoption depends heavily on professional confidence and patient outcomes.\u003c\/p\u003e\n\u003cp\u003eIn business model terms, these events do not just promote products. They build credibility, support education, and strengthen relationships that influence future prescriptions and account loyalty.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eClinical sessions support evidence-based discussion of lens performance and patient fit.\u003c\/li\u003e\n \u003cli\u003eSymposium events bring together practitioners, educators, and commercial teams.\u003c\/li\u003e\n \u003cli\u003eEducational presence can influence product consideration before the next prescribing cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Customer Segments\u003c\/h2\u003e\n\n\u003cp\u003eThe Cooper Companies, Inc. serves \u003cstrong\u003e5\u003c\/strong\u003e core customer groups across \u003cstrong\u003e2\u003c\/strong\u003e operating businesses: eye care and women's health. Its customer mix is split between professional buyers, end users, and clinical institutions, which gives the company both recurring demand and procedure-based demand.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCustomer segment\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBuyer type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eTypical purchase behavior\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003e\u003cstrong\u003eBusiness impact\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOptometrists and ophthalmologists\u003c\/td\u003e\n\u003ctd\u003eProfessional buyer\u003c\/td\u003e\n\u003ctd\u003eRecurring product selection, fitting, prescribing, and follow-up\u003c\/td\u003e\n \u003ctd\u003eDrives prescription volume and repeat patient switching\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContact lens wearers\u003c\/td\u003e\n\u003ctd\u003eEnd user\u003c\/td\u003e\n\u003ctd\u003eMonthly, biweekly, and daily replacement purchases\u003c\/td\u003e\n \u003ctd\u003eCreates recurring consumable demand\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMyopia management patients\u003c\/td\u003e\n\u003ctd\u003eClinical end user\u003c\/td\u003e\n\u003ctd\u003eLong-duration treatment use\u003c\/td\u003e\n\u003ctd\u003eSupports premium pricing and long patient lifetime value\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFertility clinics and patients\u003c\/td\u003e\n\u003ctd\u003eInstitutional buyer and end user\u003c\/td\u003e\n\u003ctd\u003eProcedure-driven, clinic-led purchasing\u003c\/td\u003e\n\u003ctd\u003eTies demand to IVF and assisted reproduction activity\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals and healthcare providers\u003c\/td\u003e\n\u003ctd\u003eInstitutional buyer\u003c\/td\u003e\n\u003ctd\u003eCase-by-case procurement and clinical use\u003c\/td\u003e\n \u003ctd\u003eSupports surgical and medical device sales\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eOptometrists and ophthalmologists\u003c\/strong\u003e are the main professional gatekeepers for the eye-care business. They select fitting parameters, recommend replacement schedules, and influence brand choice. This segment matters because a recommendation from a clinician often determines whether a patient starts and stays on a contact lens brand. In academic work, you can treat this as a channel-driven business model where the professional buyer shapes downstream consumer demand.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003ePrescription-based recommendation power\u003c\/li\u003e\n\u003cli\u003eRepeat interaction with the same patients\u003c\/li\u003e\n \u003cli\u003eInfluence over premium product adoption\u003c\/li\u003e\n\u003cli\u003eSupport for new modalities such as daily disposable lenses\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eContact lens wearers\u003c\/strong\u003e are the largest end-user segment for the eye-care business. Their demand is recurring because contact lenses are consumables with replacement cycles. This matters because recurring purchase behavior usually supports more stable revenue than one-time equipment sales. The segment includes daily, biweekly, and monthly wearers, and it is closely linked to vision correction, lifestyle preference, and convenience.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eRecurring replacement purchases\u003c\/li\u003e\n\u003cli\u003ePrice sensitivity varies by replacement cycle\u003c\/li\u003e\n \u003cli\u003eConvenience and comfort influence retention\u003c\/li\u003e\n \u003cli\u003eFit quality affects long-term loyalty\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eMyopia management patients\u003c\/strong\u003e are a specialized eye-care segment with longer treatment horizons. Myopia means nearsightedness, and management usually aims to slow progression in children and adolescents. This segment matters because it supports premium clinical products and longer patient relationships than standard vision correction. For academic analysis, this is a strong example of a preventive-care customer segment where clinical outcomes and long-term usage are linked.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eChildren and adolescents are the core patient base\u003c\/li\u003e\n \u003cli\u003eLong treatment duration increases customer lifetime value\u003c\/li\u003e\n \u003cli\u003eClinical adoption depends on practitioner confidence\u003c\/li\u003e\n \u003cli\u003eFamily willingness to pay affects market penetration\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFertility clinics and patients\u003c\/strong\u003e are the central customer group for the women's health business. Clinics buy products used in assisted reproductive procedures, while patients are the indirect demand source because they drive treatment volume. This segment matters because demand depends on procedure counts, clinic adoption, and the economics of fertility treatment. It is less about frequent retail repurchase and more about specialized clinical use.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eClinic-led procurement\u003c\/li\u003e\n\u003cli\u003eProcedure-linked demand\u003c\/li\u003e\n\u003cli\u003eHigh clinical specificity\u003c\/li\u003e\n\u003cli\u003eIndirect patient demand through treatment cycles\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eHospitals and healthcare providers\u003c\/strong\u003e are important institutional customers across the women's health business and related clinical settings. These buyers care about reliability, compliance, and integration into clinical workflows. This segment matters because hospital purchasing can be sticky once a product is embedded in practice patterns or procurement contracts. In academic writing, this is a clear example of B2B healthcare selling with long decision cycles and clinical validation requirements.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eInstitutional procurement process\u003c\/li\u003e\n\u003cli\u003eEmphasis on clinical evidence and regulatory compliance\u003c\/li\u003e\n \u003cli\u003eLonger sales cycles than consumer products\u003c\/li\u003e\n \u003cli\u003eNeed for training, service, and product consistency\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSegment\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eDemand driver\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eRevenue pattern\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eStrategic importance\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOptometrists and ophthalmologists\u003c\/td\u003e\n\u003ctd\u003ePrescribing and fitting\u003c\/td\u003e\n\u003ctd\u003eRecurring\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContact lens wearers\u003c\/td\u003e\n\u003ctd\u003eReplacement cycles\u003c\/td\u003e\n\u003ctd\u003eRecurring consumable\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMyopia management patients\u003c\/td\u003e\n\u003ctd\u003eLong-term treatment\u003c\/td\u003e\n\u003ctd\u003eRecurring clinical use\u003c\/td\u003e\n\u003ctd\u003eRising\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFertility clinics and patients\u003c\/td\u003e\n\u003ctd\u003eIVF and assisted reproduction activity\u003c\/td\u003e\n\u003ctd\u003eProcedure-linked\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals and healthcare providers\u003c\/td\u003e\n\u003ctd\u003eClinical procurement\u003c\/td\u003e\n\u003ctd\u003eContract and case-based\u003c\/td\u003e\n\u003ctd\u003eModerate to high\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe customer structure shows a mix of B2B and B2C demand. B2B customers such as clinics, hospitals, optometrists, and ophthalmologists influence product access, while end users such as contact lens wearers and fertility patients determine actual usage. That mix matters because it reduces reliance on a single demand channel and gives the company multiple routes to growth through clinical adoption and patient demand.\u003c\/p\u003e\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Cost Structure\u003c\/h2\u003e\n\n\u003cp\u003eThe Cooper Companies, Inc. is a cost-heavy medical device business with spending concentrated in manufacturing, product development, selling infrastructure, distribution, and compliance. Its cost base is shaped by two operating businesses, CooperVision and CooperSurgical, both of which rely on regulated production, clinical innovation, and global delivery networks.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCost structure area\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eReal-life cost indicator\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003e\u003cstrong\u003eBusiness impact\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing and production\u003c\/td\u003e\n\u003ctd\u003eCOGS is the main operating cost bucket before gross profit\u003c\/td\u003e\n \u003ctd\u003eDirectly determines gross margin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D and product development\u003c\/td\u003e\n\u003ctd\u003eRecurring annual expense tied to new lenses, surgical products, and regulatory work\u003c\/td\u003e\n \u003ctd\u003eSupports pipeline growth and replacement cycles\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSales and marketing\u003c\/td\u003e\n\u003ctd\u003eField sales, physician education, and channel support across global markets\u003c\/td\u003e\n \u003ctd\u003eDrives customer acquisition and retention\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics and distribution\u003c\/td\u003e\n\u003ctd\u003eWarehousing, freight, customs, and inventory handling\u003c\/td\u003e\n \u003ctd\u003eAffects service levels and working capital\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIT remediation and compliance\u003c\/td\u003e\n\u003ctd\u003eCybersecurity, ERP, privacy, and regulatory controls\u003c\/td\u003e\n \u003ctd\u003eProtects operations and reduces legal and operating risk\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eManufacturing and production\u003c\/strong\u003e are the largest structural cost drivers. The company makes contact lenses, surgical products, and related medical devices in regulated facilities, so it carries fixed costs for plant labor, clean-room operations, quality assurance, validation, and depreciation. These costs matter because they sit inside cost of goods sold and shape gross margin. In fiscal 2024, the company reported gross margin of \u003cstrong\u003e69.5%\u003c\/strong\u003e, which shows that manufacturing efficiency is central to profitability. A higher gross margin means more revenue is left after production costs to cover R\u0026amp;D, sales, administration, and compliance.\u003c\/p\u003e\n\n\u003cp\u003eProduction costs also rise with regulatory requirements. Medical device manufacturing needs traceability, testing, batch control, and documentation. That makes the cost base less flexible than in consumer products. When volumes rise, the company can spread fixed plant costs over more units. When volumes weaken, those fixed costs pressure margins.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePlant labor and benefits\u003c\/li\u003e\n\u003cli\u003eRaw materials and components\u003c\/li\u003e\n\u003cli\u003eClean-room and sterilization expenses\u003c\/li\u003e\n\u003cli\u003eQuality control and validation\u003c\/li\u003e\n\u003cli\u003eDepreciation of manufacturing equipment\u003c\/li\u003e\n\u003cli\u003eScrap, yield loss, and rework\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eR\u0026amp;D and product development\u003c\/strong\u003e are recurring costs because the company competes on product performance, fit, comfort, and surgical outcomes. In medical devices, R\u0026amp;D is not optional overhead. It supports new product launches, line extensions, clinical testing, and regulatory submissions. The company reported research and development expense of \u003cstrong\u003e$131.3 million\u003c\/strong\u003e in fiscal 2024. That spending is important because it protects pricing power and supports future sales growth, especially in categories where customers switch based on clinical performance and practitioner preference.\u003c\/p\u003e\n\n\u003cp\u003eR\u0026amp;D also links to the life cycle of the company's products. Contact lenses and surgical products face replacement pressure from newer technologies, so the company must keep investing to stay relevant. In cost structure terms, R\u0026amp;D is a long-duration expense: it reduces near-term profit but can improve future revenue quality and margin stability.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFiscal 2024 expense item\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003e\u003cstrong\u003eAmount\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch and development expense\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$131.3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e69.5%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eSales and marketing\u003c\/strong\u003e are meaningful because the company sells through healthcare professionals, distributors, and clinical channels. This means spending goes toward field sales teams, professional education, account management, advertising, and product support. In fiscal 2024, selling, general and administrative expense was \u003cstrong\u003e$1.1 billion\u003c\/strong\u003e. That figure includes sales and marketing plus corporate overhead, so it is a major part of the cost structure. The reason it matters is simple: in medical devices, sales effort is tied to adoption. If doctors, clinics, and surgical centers do not know the product or trust the brand, revenue does not scale.\u003c\/p\u003e\n\n\u003cp\u003eSales costs are also tied to geography. A global business has language, country, and regulatory differences that require local support. That increases personnel costs, travel, training, and compliance coordination. For a company with products sold across many markets, sales spending is not just promotion. It is market access.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eField sales compensation\u003c\/li\u003e\n\u003cli\u003eClinical education and training\u003c\/li\u003e\n\u003cli\u003eChannel incentives and account support\u003c\/li\u003e\n\u003cli\u003eTrade shows and professional outreach\u003c\/li\u003e\n\u003cli\u003eCustomer service and technical support\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eLogistics and distribution\u003c\/strong\u003e are a structural cost because the company ships regulated products with inventory, temperature, handling, and service-level requirements. The business needs warehouses, third-party logistics providers, international freight, import and export handling, and inventory controls. This cost area affects both expense and working capital. If inventory is too high, cash gets tied up. If inventory is too low, service failures can hurt sales.\u003c\/p\u003e\n\n\u003cp\u003eDistribution is especially important for contact lenses, where replenishment cycles and customer service matter. Fast, accurate delivery supports retention. Delays can cause backorders, lost prescriptions, and higher expedited freight costs. Logistics costs therefore affect both margins and customer experience.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLogistics cost component\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003e\u003cstrong\u003eOperating effect\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWarehousing\u003c\/td\u003e\n\u003ctd\u003eInventory holding and facility expense\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFreight and shipping\u003c\/td\u003e\n\u003ctd\u003eDelivery speed and unit cost pressure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustoms and trade compliance\u003c\/td\u003e\n\u003ctd\u003eCross-border delays and documentation costs\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory management\u003c\/td\u003e\n\u003ctd\u003eWorking capital and obsolescence risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eIT remediation and compliance\u003c\/strong\u003e are increasingly important cost items because the company operates in regulated healthcare markets and depends on secure information systems. This includes cybersecurity, data privacy, ERP support, access controls, validation, audit readiness, and remediation work when systems need fixing or upgrading. These are not optional costs. They are required to protect patient data, maintain manufacturing continuity, and support regulatory compliance.\u003c\/p\u003e\n\n\u003cp\u003eFor a medical device company, IT spending affects production, finance, and sales at the same time. If systems fail, it can disrupt order processing, quality documentation, inventory tracking, and reporting. Compliance spending also helps reduce the risk of fines, recalls, and operational disruption. In cost structure terms, this is a protective cost that does not directly create revenue but helps preserve revenue and margin.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCybersecurity monitoring and response\u003c\/li\u003e\n\u003cli\u003eERP maintenance and remediation\u003c\/li\u003e\n\u003cli\u003eAccess control and data governance\u003c\/li\u003e\n\u003cli\u003eRegulatory documentation systems\u003c\/li\u003e\n\u003cli\u003ePrivacy and compliance training\u003c\/li\u003e\n\u003cli\u003eAudit and validation support\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFiscal 2024\u003c\/strong\u003e shows the scale of the company's operating cost base through its main expense lines: \u003cstrong\u003e$131.3 million\u003c\/strong\u003e in R\u0026amp;D, \u003cstrong\u003e$1.1 billion\u003c\/strong\u003e in selling, general and administrative expense, and \u003cstrong\u003e69.5%\u003c\/strong\u003e gross margin. These numbers show a business that depends on efficient production, sustained innovation, and a large commercial and compliance organization to support global sales.\u003c\/p\u003e\u003ch2\u003eThe Cooper Companies, Inc. - Canvas Business Model: Revenue Streams\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003e$3.9 billion\u003c\/strong\u003e in fiscal 2024 net sales.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue stream\u003c\/td\u003e\n\u003ctd\u003eFiscal 2024 net sales\u003c\/td\u003e\n\u003ctd\u003eShare of total net sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContact lens sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.9 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e75%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFertility business sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.0 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e25%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.9 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e100%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eContact lens sales\u003c\/strong\u003e: \u003cstrong\u003e$2.9 billion\u003c\/strong\u003e in fiscal 2024.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e75%\u003c\/strong\u003e of net sales.\u003c\/li\u003e\n\u003cli\u003eCooperVision segment revenue: \u003cstrong\u003e$2.9 billion\u003c\/strong\u003e.\u003c\/li\u003e\n \u003cli\u003eCooperSurgical segment revenue: \u003cstrong\u003e$1.0 billion\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eFertility business sales\u003c\/strong\u003e: \u003cstrong\u003e$1.0 billion\u003c\/strong\u003e in fiscal 2024.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e25%\u003c\/strong\u003e of net sales.\u003c\/li\u003e\n\u003cli\u003eCooperSurgical segment revenue: \u003cstrong\u003e$1.0 billion\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003ePremium lens product sales\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eCategory\u003c\/td\u003e\n\u003ctd\u003eReported amount\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperVision revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.9 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompany net sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.9 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperVision share of net sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e75%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRegional product sales\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e75%\u003c\/strong\u003e of company net sales came from CooperVision in fiscal 2024.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003e25%\u003c\/strong\u003e of company net sales came from CooperSurgical in fiscal 2024.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eService and solution revenues\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eBusiness line\u003c\/td\u003e\n\u003ctd\u003eFiscal 2024 net sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperSurgical\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.0 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCooperVision\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.9 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.9 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":44601591136405,"sku":"coo-business-model-canvas","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/coo-business-model-canvas.png?v=1740222109","url":"https:\/\/dcf-model.com\/fr\/products\/coo-business-model-canvas","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}